-
Study aim
-
Determining and comparing the effect of platelet-rich fibrin membrane and melatonin on nerve recovery following mandibular fractures
-
Design
-
The clinical trial has a control group, with factorial groups, double-blind, randomized, phase 3 on 45 patients, and permutation blocks were used for randomization.
-
Settings and conduct
-
In group 1, after exposing the fracture area, in cases of involvement of the lower alveolar canal, PRF prepared from the patient's blood is placed inside the bone and on the canal, and then bone reduction and fixation are performed . In cases of exposure of the mental nerve, the fibrin membrane is placed directly on the nerve in the exit area of the foramen and is supported by an absorbable collagen membrane and absorbable suture.
In group 2, 10 mg melatonin capsules were given to the patients the night before surgery and then one capsule every night until 21 days after surgery. Reduction and fixation of fracture lines will be done as in group 1.
In group 3, reduction and fixation of fracture lines will be performed as the control group.
In this study the examiner and the patient are blind to the type of intervention.
-
Participants/Inclusion and exclusion criteria
-
Entry requirements:
Patients with minimal displacement Fractures that require open mandibular fracture treatment
Patients with no history of sensitivity to melatonin
Non-entry conditions:
Patients who have severed nerve fibers at the fracture site
Patients who have soft tissue injuries in the lower lip and chin area.
-
Intervention groups
-
In group 1, patients are treated with platelet-rich fibrin membrane.
In group 2, patients are treated with melatonin.
In group 3 (control), reduction and fixation of fracture lines will be performed.
-
Main outcome variables
-
Improving the para-esthesia of the lower lip and chin caused by mandibular fracture, using platelet-rich fibrin membrane or melatonin